Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

Clear filters
ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 24 matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
Filters: Condition: HCG Clear all
Terminated Phase 2 Interventional Results available

Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients

NCT00938314
View directory record Official record
Conditions
Stroke
Interventions
human chorionic gonadotropin (hCG), then epoetin alfa (EPO), Saline Placebo
Drug
Lead sponsor
Stem Cell Therapeutics Corp.
Industry
Eligibility
18 Years to 85 Years
Enrollment
96 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2010
U.S. locations
1
States / cities
Orange, California
Source: ClinicalTrials.gov public record
Updated Nov 28, 2011 · Synced Jul 22, 2026, 4:51 PM EDT
Active, not recruiting No phase listed Observational

Assessment of Early Pregnancy MAB Completion

NCT06893484
View directory record Official record
Conditions
Pregnancy, Abortion Early
Interventions
Weekly high-sensitivity urine pregnancy tests
Diagnostic Test
Lead sponsor
University of Washington
Other
Eligibility
Female only
Enrollment
400 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2026
U.S. locations
3
States / cities
Atlanta, Georgia • Chevy Chase, Maryland • Renton, Washington
Source: ClinicalTrials.gov public record
Updated May 7, 2026 · Synced Jul 22, 2026, 4:51 PM EDT
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Administration of Follicle-stimulating Hormone (FSH) and Low Dose Human Chorionic Gonadotropin (hCG) for Oocyte Maturity While Decreasing hCG Exposure in In Vitro Fertilization (IVF) Cycles

NCT02310919
View directory record Official record
Conditions
Infertility
Interventions
Low dose hCG plus FSH co-trigger, Standard dose of hCG
Drug
Lead sponsor
University of California, San Francisco
Other
Eligibility
18 Years to 41 Years · Female only
Enrollment
105 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2014 – 2018
U.S. locations
1
States / cities
San Francisco, California
Source: ClinicalTrials.gov public record
Updated Apr 28, 2022 · Synced Jul 22, 2026, 4:51 PM EDT
Completed No phase listed Observational Accepts healthy volunteers

Performance Evaluation Study for Clearblue Pregnancy Test

NCT01077583
View directory record Official record
Conditions
Pregnancy
Interventions
Not listed
Lead sponsor
SPD Development Company Limited
Industry
Eligibility
18 Years to 45 Years · Female only
Enrollment
800 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2010 – 2011
U.S. locations
5
States / cities
Atlanta, Georgia • Chicago, Illinois • Edina, Minnesota + 2 more
Source: ClinicalTrials.gov public record
Updated Sep 27, 2011 · Synced Jul 22, 2026, 4:51 PM EDT
Completed No phase listed Observational

Sofia hCG FIA Field Study

NCT01803113
View directory record Official record
Conditions
Pregnancy, Early Detection
Interventions
Sofia hCG FIA
Device
Lead sponsor
Quidel Corporation
Industry
Eligibility
Female only
Enrollment
975 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013
U.S. locations
5
States / cities
Boynton Beach, Florida • Fall River, Massachusetts • Pawtucket, Rhode Island + 1 more
Source: ClinicalTrials.gov public record
Updated Mar 12, 2013 · Synced Jul 22, 2026, 4:51 PM EDT
Not yet recruiting No phase listed Observational Accepts healthy volunteers

Predicate and Lay User-HCP Comparison Study of a Multi-Level Urine hCG Pregnancy Test

NCT06516211
View directory record Official record
Conditions
Pregnancy
Interventions
Clara Pregnancy Test, Professional Marketed Pregnancy Test
Device
Lead sponsor
Conceptra Biosciences, LLC
Industry
Eligibility
18 Years and older · Female only
Enrollment
180 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2026 – 2027
U.S. locations
1
States / cities
Los Angeles, California
Source: ClinicalTrials.gov public record
Updated Mar 18, 2026 · Synced Jul 22, 2026, 4:51 PM EDT
Completed Phase 1 Interventional

A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01)

NCT00709462
View directory record Official record
Conditions
Breast Cancer, Colorectal Cancer, Pancreatic Cancer, Bladder Cancer, Ovarian Cancer
Interventions
CDX1307
Biological
Lead sponsor
Celldex Therapeutics
Industry
Eligibility
18 Years and older
Enrollment
48 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2004 – 2010
U.S. locations
3
States / cities
Detroit, Michigan • Durham, North Carolina • Huntersville, North Carolina
Source: ClinicalTrials.gov public record
Updated Jul 25, 2010 · Synced Jul 22, 2026, 4:51 PM EDT
Completed No phase listed Observational Accepts healthy volunteers

Clearblue Pregnancy Test Lay User Usage Study

NCT04746014
View directory record Official record
Conditions
Pregnancy
Interventions
Clearblue Pregnancy Test
Diagnostic Test
Lead sponsor
SPD Development Company Limited
Industry
Eligibility
18 Years and older · Female only
Enrollment
306 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2021
U.S. locations
1
States / cities
Cypress, California
Source: ClinicalTrials.gov public record
Updated Aug 5, 2021 · Synced Jul 22, 2026, 4:51 PM EDT
Withdrawn Phase 3 Interventional Accepts healthy volunteers

Doravirine and Weight Gain in Antiretroviral Naive

NCT05457530
View directory record Official record
Conditions
Body Weight Changes, Human Immunodeficiency Virus, ART, Obesity, Minority Health, BMD, Metabolic Syndrome, Fasting
Interventions
DOR/3TC/TDF, DOR + FTC/TAF, BIC/FTC/TAF
Drug · Combination Product
Lead sponsor
Prism Health North Texas
Other
Eligibility
18 Years and older · Female only
Healthy volunteers
Accepts healthy volunteers
Timeline
2022 – 2023
U.S. locations
1
States / cities
Dallas, Texas
Source: ClinicalTrials.gov public record
Updated May 11, 2023 · Synced Jul 22, 2026, 4:51 PM EDT
Completed Not applicable Interventional

Medical Abortion Self-Confirmation (MASC)

NCT03148587
View directory record Official record
Conditions
Medical Abortion
Interventions
Self-assessment: MLPT, Self-assessment: LSPT
Behavioral
Lead sponsor
Stanford University
Other
Eligibility
18 Years and older · Female only
Enrollment
88 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017 – 2018
U.S. locations
1
States / cities
Stanford, California
Source: ClinicalTrials.gov public record
Updated Jun 6, 2019 · Synced Jul 22, 2026, 4:51 PM EDT
Not listed No phase listed Observational

Preterm Delivery Risk Prediction by Measurement of Prenatal Serum Screening Markers

NCT01009723
View directory record Official record
Conditions
Preterm Delivery
Interventions
Not listed
Lead sponsor
Esoterix Genetic Laboratories, LLC
Industry
Eligibility
18 Years and older · Female only
Enrollment
2,000 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2010 – 2012
U.S. locations
2
States / cities
Westborough, Massachusetts • Santa Fe, New Mexico
Source: ClinicalTrials.gov public record
Updated Jun 7, 2012 · Synced Jul 22, 2026, 4:51 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

The Role of a Semi-Quantitative Urine Pregnancy Test and Pregnancy Questionnaire After Uterine Evacuation for Undesired Pregnancy of Uncertain Location

NCT01596972
View directory record Official record
Conditions
Follow-up After Uterine Evacuation
Interventions
dBest semi-quantitative urine pregnancy test
Device
Lead sponsor
Planned Parenthood League of Massachusetts
Other
Eligibility
18 Years and older · Female only
Enrollment
51 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2012 – 2013
U.S. locations
1
States / cities
Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Jun 30, 2014 · Synced Jul 22, 2026, 4:51 PM EDT
Not listed Phase 3 Interventional

Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women

NCT00808522
View directory record Official record
Conditions
Breast Cancer
Interventions
hCG
Drug
Lead sponsor
New York Presbyterian Hospital
Other
Eligibility
30 Years to 75 Years · Female only
Enrollment
84 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2008 – 2009
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated Dec 15, 2008 · Synced Jul 22, 2026, 4:51 PM EDT
Recruiting Phase 4 Interventional Accepts healthy volunteers

The Role of hCG in Thawed Embryo Transfer

NCT07004192
View directory record Official record
Conditions
Infertility (IVF Patients)
Interventions
HCG injection, No intervention
Drug · Other
Lead sponsor
Fertility Center of Las Vegas
Industry
Eligibility
18 Years and older · Female only
Enrollment
220 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2025 – 2027
U.S. locations
1
States / cities
Las Vegas, Nevada
Source: ClinicalTrials.gov public record
Updated Jun 30, 2025 · Synced Jul 22, 2026, 4:51 PM EDT
Completed Phase 1 Interventional

Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer

NCT00648102
View directory record Official record
Conditions
Breast Cancer, Colorectal Cancer, Pancreatic Cancer, Bladder Cancer, Ovarian Cancer
Interventions
CDX-1307
Biological
Lead sponsor
Celldex Therapeutics
Industry
Eligibility
18 Years and older
Enrollment
36 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2006 – 2009
U.S. locations
3
States / cities
Detroit, Michigan • Durham, North Carolina • Huntersville, North Carolina
Source: ClinicalTrials.gov public record
Updated Jul 25, 2010 · Synced Jul 22, 2026, 4:51 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.

NCT00223860
View directory record Official record
Conditions
Hypogonadism, Spinal Cord Injury
Interventions
Human chorionic gonadotropin (hCG), Luteinizing hormone releasing hormone (LHRH)
Drug
Lead sponsor
US Department of Veterans Affairs
Federal
Eligibility
18 Years to 65 Years · Male only
Enrollment
100 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2001 – 2007
U.S. locations
1
States / cities
The Bronx, New York
Source: ClinicalTrials.gov public record
Updated Mar 10, 2008 · Synced Jul 22, 2026, 4:51 PM EDT
Recruiting Not applicable Interventional Accepts healthy volunteers

MIRA CONNECT Study

NCT06802263
View directory record Official record
Conditions
Pregnancy of Unknown Location (PUL)
Interventions
at-home quantitative urine b-hCG test
Diagnostic Test
Lead sponsor
University of Colorado, Denver
Other
Eligibility
18 Years to 40 Years · Female only
Enrollment
35 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2024 – 2027
U.S. locations
1
States / cities
Aurora, Colorado
Source: ClinicalTrials.gov public record
Updated Sep 15, 2025 · Synced Jul 22, 2026, 4:51 PM EDT
Not yet recruiting Early Phase 1 Interventional

hCG Treatment for Rehabilitation From a TBI

NCT07557615
View directory record Official record
Conditions
Traumatic Brain Injury
Interventions
Ovidrel, Placebo
Drug · Other
Lead sponsor
VA Office of Research and Development
Federal
Eligibility
18 Years to 65 Years · Male only
Enrollment
50 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2029
U.S. locations
1
States / cities
Madison, Wisconsin
Source: ClinicalTrials.gov public record
Updated May 5, 2026 · Synced Jul 22, 2026, 4:51 PM EDT
Not listed No phase listed Observational Accepts healthy volunteers

Detection of Urinary Human Chorionic Gonadotropin (hCG)

NCT05458778
View directory record Official record
Conditions
Pregnancy Detection
Interventions
Daily test with urine by the product
Device
Lead sponsor
Quanovate Tech Inc.
Industry
Eligibility
18 Years to 80 Years · Female only
Enrollment
200 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022 – 2023
U.S. locations
1
States / cities
San Ramon, California
Source: ClinicalTrials.gov public record
Updated Apr 30, 2023 · Synced Jul 22, 2026, 4:51 PM EDT
Not yet recruiting No phase listed Observational

Comparison of Beta-hCG Levels When Using Venous Puncture Blood and Peripheral Finger Stick Blood

NCT07493720
View directory record Official record
Conditions
Pregnancy
Interventions
Beta-hCG
Diagnostic Test
Lead sponsor
University of Nebraska
Other
Eligibility
19 Years and older · Female only
Enrollment
40 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026
U.S. locations
1
States / cities
Omaha, Nebraska
Source: ClinicalTrials.gov public record
Updated Mar 24, 2026 · Synced Jul 22, 2026, 4:51 PM EDT
Not listed Not applicable Interventional Accepts healthy volunteers

Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters

NCT00006445
View directory record Official record
Conditions
Down Syndrome, Chromosome Abnormalities
Interventions
Ultrasound, Serum screen
Procedure
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Eligibility
16 Years to 45 Years · Female only
Enrollment
38,000 participants
Healthy volunteers
Accepts healthy volunteers
U.S. locations
10
States / cities
Denver, Colorado • Boston, Massachusetts • Royal Oak, Michigan + 6 more
Source: ClinicalTrials.gov public record
Updated Feb 21, 2007 · Synced Jul 22, 2026, 4:51 PM EDT
Completed No phase listed Observational Accepts healthy volunteers

Clinical Investigation for the Preview® hCG Urine/Serum Combo Pregnancy Test

NCT04207554
View directory record Official record
Conditions
Pregnancy
Interventions
Test Device-Strip Format, Test Device-Cassette Format, Predicate Device
Device
Lead sponsor
Guangzhou Wondfo Biotech Co., Ltd
Industry
Eligibility
18 Years and older · Female only
Enrollment
132 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2019 – 2020
U.S. locations
6
States / cities
Garden Grove, California • Huntington Park, California • Los Angeles, California + 2 more
Source: ClinicalTrials.gov public record
Updated Jan 10, 2021 · Synced Jul 22, 2026, 4:51 PM EDT
Completed No phase listed Observational

Non-invasive Chromosomal Examination of Trisomy Study

NCT01511458
View directory record Official record
Conditions
Trisomy 21
Interventions
Not listed
Lead sponsor
Roche Sequencing Solutions
Industry
Eligibility
18 Years to 60 Years · Female only
Enrollment
18,955 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012 – 2014
U.S. locations
26
States / cities
Tucson, Arizona • Oakland, California • Palo Alto, California + 20 more
Source: ClinicalTrials.gov public record
Updated Jul 13, 2014 · Synced Jul 22, 2026, 4:51 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Injection of Hormone to Enhance Implantation in Embryo Transfer After IVF

NCT01986374
View directory record Official record
Conditions
Infertility
Interventions
HCG is introduced
Drug
Lead sponsor
Servy Massey Fertility Insititute
Other
Eligibility
21 Years to 47 Years · Female only
Enrollment
75 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2013 – 2016
U.S. locations
1
States / cities
Atlanta, Georgia
Source: ClinicalTrials.gov public record
Updated Mar 18, 2020 · Synced Jul 22, 2026, 4:51 PM EDT